Abstract
The aims of after-care in the follow-up are to lengthen survival time and to improve quality of life as well (fig. 1.1). Recurrence prevention, early detection of recurrences and therapy of disease recurrence (potentially curative follow-up measures) serve to lengthen survival time (fig. 1.3). Supportive, rehabilitative and palliative measures serve to improve quality of life and activities of daily living (fig. 1.2).
Keywords
- Lung Cancer
- Chronic Obstructive Pulmonary Disease
- Brain Metastasis
- Lung Cancer Patient
- Radiation Pneumonitis
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
Bibliography
— AARC Clinical Practice Guideline (2002) Pulmonary rehabilitation. Respir Care 47(5): 617–25
— Abid SH, Malhotra V, Perry MC (2001) Radiation-induced and chemotherapy-induced pulmonary injury. Curr Opin Oncol 13: 242–8
— Abrahm J (2004) Assessment and treatment of patients with malignant spinal cord compression. J Support Oncol 2: 377–401
— Algar FJ, Alvarez A, alvatierra A et al. (2002) Predicting pulmonary complications after pneumonectomy for lung cancer. Eur J Cardiothorac Surg 2003; 23: 201–8
— Ampil F, Caldito G (2006) Radiotherapy for palliation of lung cancer in patients with compromised hearts. J Pall Med 9,2: 241–2
— Akira M, Ishikawa H, Yamamoto S (2002) Drug-induced Pneumonitis: Thin-Section CT Findings in 60 Patients Radiology 224: 852–60
— Arbeiter K, Prakash U, Tazelaar H et al. (1999) Radiation-Induced Pneumonitis in the “Non-Irradiated” Lung. Mayo Clin Proc. 74: 27–36
— Aspinal F, Hughes R, Higginson I et al. (2002) A user’s guide to the palliative care outcome scale. Palliative care & policy publications. Kings College, London
— Barat M, Franchignoni F (2004) Assessment in physical medicine and rehabilitation. Maugeri Foundation Books, PI-ME Press Pavia
— Bausewein C, Fegg M, Radbruch L et al. (2005) Validation and clinical application of the German version of the palliative care outcome. J Pain Symptom Manage 30: 51–62
— Bergman B, Aaronson N et al. (1994) The EORTC QLQ-LC13: a modular supplement to the EORTC Core Quality of Life Questionnaire for use in lung cancer clinical trials. Eur J Cancer 30A, 635–42
— Bruera E, Ripamonti C (1998) Dyspnea in Patients with Advanced Cancer in Supportive Oncology. Berger A, Portenoy R, Weissman D, ed., Lippincott-Raven, 295–308
— Bundesarbeitsgemeinschaft für Rehabilitation (2003) Rahmenempfehlungen zur ambulanten onkologischen Rehabilitation. Bundesarbeitsgemeinschaft für Rehabilitation Frankfurt
— Bunn PA, Lilenbaum R (2003) Chemotherapy for elderly patients with advanced non-small-cell lung cancer. J Natl Cancer Inst, 5,95: 341–3
— Cella D, Bonomi A et al. (1995) Reliability and validity of the functional assessment of cancer therapy-lung (Fact-L) quality of life instrument. Lung Cancer 12,3: 199–220
— Cella D (1997) The functional assessment of cancer therapy anaemia (FACT-An) scale: A new tool for the assessment of outcomes in cancer anemia and fatigue. Semin Hematol 34(suppl 2): 13–9
— Celli BR (2004) Chronic respiratory failure after lung resection: the role of pulmonary rehabilitation. Thorac Surg Clin 14,3: 417–28
— Chanan A, Srinivasan S, Czuczman M (2004) Prevention and management of cardiotoxicity from antineoplastic therapy. J Support Oncol 2: 251–66
— Colchen A, Gonin F, Bonnette P (2004) The place of interventional endoscopy in the treatment of lung cancer. Rev Pneumol Clin 60,3: 48–50
— Covey, A (2005) Management of malignant pleural effusions and ascites. J Support Oncol 3:169–76
— Delbrück H, Schmid L, Bartsch H et al. (2000) Zur Ergebnisqualität in der onkologischen Rehabilitation. Rehabilitation 39: 359–62
— De Gregorio Ariza MA, Gamboa P, Gimeno M et al. (2003) Percutaneous treatment of superior vena cava syndrome using metallic stents. Eur Radiol 8: 252–63
— Deschamps, Bernard A, Nichols C et al. (2001) Empyema and brochopleural fistula after pneumonectomy: Factors affecting incidence. Ann. Thorac Surg 72: 243–8
— Donner CF (2006) Vocational rehabilitation and pulmonary programs. In: Gobelet C, Franchignoni F (Edit) Vocational rehabilitation Springer Paris 185–194
— Dorman U, Weis J, Bartsch HH (2006) Qualitätssicherung in der onkologischen Rehabilitation. Der Onkologe, Heidelberg (in Press)
— Dubey S, Brown R, Esmond S et al. (2005) Patient preferences in choosing chemotherapy regiments for advanced non-small cell lung cancer. J Support Oncol 3: 149–54
— Dubois A, Schlaich M et al. (1999) Evaluation of neurotoxicity induced by paclitaxel second-line chemotherapy. Support Care cancer 7: 354
— Dunton JC (2002) Management of treatment-related toxicity in advanced ovarian cancer. Oncologist 7: 11–9
— Earle C, Tsai JS, Gelber RD (2001) Effectiveness of chemotherapy for advanced lung cancer in the elderly. J Clin Oncol 19,4: 1064–70
— Edel H, Knauth K (1999) Grundzüge der Atemtherapie Urban & Fischer, München
— ESMO (2001) Minimum clinical recommendations for diagnosis, treatment and follow-up of small-cell cancer. Ann Oncol 12: 1051
— ESMO (2001) Minimum clinical recommendations for diagnosis, treatment and follow-up of non small cell cancer. Ann Oncol 12: 1049
— Estfan B, LeGrand S (2004) Management of cough in advanced cancer. J Support Oncol 2: 523–7
— Freitag L (2004) Interventional endoscopic treatment. Lung Cancer 45,2: 235–8
— Fromme E, Eilers KM, Mori M et al. (2004) How accurate is clinician reporting of chemotherapy adverse effects? J Clin Oncol 22,17: 3485–90
— Fryback D, Craig BM (2004) Measuring economic outcomes of cancer. J Natl Cancer Inst Monographs 33: 134–41
— Gridelli C, Perrone F, Nelli F et al. (2001) Quality of life in lung cancer patients. Annals of oncology 12,3: 21
— Harada H, Okada M, Sakamoto T et al. (2005) Functional advantage after radical segmentectomy versus lobectomy for lung cancer. Ann Thorac Surg 80,6: 2041–5
— Hill K, Amir Z et al. (2003) Do newly diagnosed lung cancer patients feel their concerns are being met? Eur J Cancer Care 12,1: 35–45
— Hollen P, Grall R et al. (1993) Quality of life assessment in individuals with lung cancer: Testing the Lung Cancer symptom Scale (LCSS). Eur J Cancer 29A,1: 551–8
— Hopwood P, Stephens RJ (2000) Depression in patients with lung cancer: Prevalence and risk factors derived from quality of life data. J clin Oncol 18,4: 893–903
— Huisman C, Smit EF, Giaccone G et al. (2000) Second—line chemotherapy in relapsing or refractory non-small cell lung cancer: A review. J Clin Oncol 18: 3722–30
— Kelly K, Bunn J (1998) Is it time to reevaluate our approach to the treatment of brain metastases in patients with non-small-cell lung cancer? Lung cancer 20: 85–91
— Korfee S, Gauler T, Hepp R et al. (2004) New targeted treatments in lung cancer — overview of clinical trials. Lung Cancer 45,2: 199–208
— Licker M, Spiliopoulos A, Frey J et al. (2005) Risk factors for early mortality and major complications following pneumonectomy for non small cell carcinoma of the lung. Chest 121: 1890–7
— Limper AH (2004) Chemotherapy-induced lung disease. Clin Chest Med 25: 53–64
— Maguire P, Pitceathly C (2002) Key communication skills and how to aquire them. BMJ 325: 697–700
— Maini C, Sciutu R, Romano L, Bergomi S (2003) Radionuclide therapy with bone seeking radionuclides in palliation of painful metastases. J Exp Clin Cancer Res 22,4: 71–4
— Mamon H, Wen PY, Loeffler JS (1999) Allergic skin reactions to anticonvulsant medications in patients receiving cranial radiation. Epilepsia 40(3): 341–4
— Mancuso A, Migliorino M, de Santis S et al. (2006) Correlation between anemia and functional/cognitive capacity in elderly lung cancer patients treated with chemotherapy. Annals of oncoloy 17: 146–150
— Miller AB et al. (2004) Fruits and vegetables and lung cancer: Findings from the European Prospective Investigation into Cancer and Nutrition. Int J Cancer 108: 269–76
— Montazeri A, Gillis CR, McEwen J (1998) Quality of life in patients with lung cancer. Chest 113: 467–81
— Muscarotili M, Bossola M, Aversa Z et al. (2006) Prevention and treatment of cancer cachexia: New insights into an old problem. Eurp J Cancer 42: 31–41
— Mutee F, Jatoi A (2006) Megestrol aceatate for the palliation of anorexia in advanced, incurable patients. Clin Nutr 6
— Neuberger JS, Field RW (2003) Occupation and lung cancer in non smokers. Rev Environ Health 18,4: 251–67
— Paice J (2003) Mechanisms and management of neuropathic pain in cancer. J support Oncol 1,2: 107–14
— Pawel J, Schiller JH, Shepherd FA et al. (1999) Topotecan versus Cyclophosphamide, Doxorubicin, and Vincristine for the Treatment of Recurrent Small-Cell Lung Cancer. J Clin Oncol 17,2: 658
— Pezner RD, Bertrand M, Cecchi G et al. (1984) Steroid-withdrawal radiation pneumonitis in cancer patients. Chest 85: 816–7
— Ramsey SD, Howlader N, Etzioni RD et al. (2004) Chemotherapy use, outcomes, and costs for older persons with advanced non-small lung cancer. J Clin Oncol 22(24): 4971–8
— Rizzo JD, Lichtin A et al. (2002) Use of epoetin in patients with cancer: Evidence-based clinical practice guidelines of the American society of clinical oncology and the American society of haematology. J Clin Oncol 20: 4083–4107
— Robnett T, Machtay M, Vines EF et al. (2000) Factors predicting severe radiation pneumonitis in patients receiving definitive chemoradiation for lung cancer. Int J Radiat Oncol Bio Phys 1,48, 1: 89–94
— Ron IG, Stav O, Vishne T et al. (2004) The correlation between palliation of bone pain by intravenous strontium 89 and external beam radiation to linked field in patients with osteoblastic bone metastases. Am J Clin Oncol 27(5): 5004
— Rosen LS, Gordon D, Tchekmedyian NS et al. (2004) Long-term efficacy and safety of zoledronic acid in the treatment of skeletal metastases in patients with non-small-cell lung cancer and other solid tumours. Cancer 100,12: 2613–21
— Schofield P, Ball D, Smith JG et al. (2004) Optimism and survival in lung carcinoma patients. Cancer 100,6: 1276–82
— Seegenschmidt M (1998) Nebenwirkungen in der Onkologie. Springer, Berlin, Heidelberg, New York, Tokyo
— Seute T, Leffers P, ten Velde GP et al. (2004) Neurologic disorders in 432 consecutive patients with small-cell lung carcinoma. Cancer 100: 801–6
— Shepherd F, Pereira J, Ciuleanu T et al. (2005) Erlotinib in previously treated Non-small-cell lung cancer. N Engl J Med 353: 123–32
— Sleijfer S (2001) Bleomycin-induced pneumonitis. Chest 120,2: 617–24
— Spruit MA, Janssen PP, Willemsen SC et al. (2006) Exercise capacity before and after an 8-week multidisciplinary inpatient rehabilitation program in lung cancer patients. Lung Cancer (Mar)
— Stanley H, Kelley K (2004) CNS home visits following diagnosis of lung cancer. Cancer Nursing Practice 3,2: 33–9
— Stinnett H, S, Williams C, Johnson D (2007) Role of chemotherapy for palliation in the lung cancer patient. J Support Oncol 5,1: 19–24
— Sugimura, Yang H (2006) Long-term Survivorship in Lung Cancer*Chest. 129: 1088–97
— Tamburini M. (2001) Health related quality of life measures in cancer. Ann Oncol 12(suppl 3): 7
— Thomas J, von Gunten C (2003) Management of dyspnea. J Support Oncol 1: 23–32
— Von Pawel J, Gatzemeier U, Pujol JL et al. (2001) Comparator of oral versus intravenous Topotecan in patients with chemosensitive small-cell lung cancer. J Clin Oncol 19: 1743–9
— Wells M, Sarna L, Cooley M et al. (2007) Use of complementary and alternative medicine therapies to control symptoms in women living with lung cancer. Cancer Nurs 30,1: 45–55
— Zatloukal P, Petrzelka L et al. (2004) Concurrent versus sequential chemo radiotherapy with cisplatin and vinorelbine in locally advanced non-small-cell lung cancer: A randomized study. Lung cancer 46,1: 87–98
Rights and permissions
Copyright information
© 2007 Springer-Verlag France, Paris
About this chapter
Cite this chapter
(2007). Rehabilitation and palliation of patients with bronchial cancer. In: Rehabilitation and palliation of cancer patients. Collection de L’Académie Européenne de Médecine de Réadaptation. Springer, Paris. https://doi.org/10.1007/978-2-287-72827-3_12
Download citation
DOI: https://doi.org/10.1007/978-2-287-72827-3_12
Publisher Name: Springer, Paris
Print ISBN: 978-2-287-72826-6
Online ISBN: 978-2-287-72827-3
eBook Packages: MedicineMedicine (R0)